369 related articles for article (PubMed ID: 26702846)
1. Opioid-induced constipation in chronic noncancer pain.
Weber HC
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
[TBL] [Abstract][Full Text] [Related]
2. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
Murphy JA; Sheridan EA
Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627
[TBL] [Abstract][Full Text] [Related]
3. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Profile of Naldemedine, a Peripherally Acting
Kanemasa T; Koike K; Takase K; Arai T; Nakamura A; Morioka Y; Hasegawa M
J Pharmacol Exp Ther; 2020 Jun; 373(3):438-444. PubMed ID: 32169839
[TBL] [Abstract][Full Text] [Related]
5. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.
Spierings EL; Brewer RP; Rauck RL; Losch-Beridon T; Mareya SM
Pain Pract; 2017 Mar; 17(3):312-319. PubMed ID: 26990171
[TBL] [Abstract][Full Text] [Related]
6. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
Rauck RL
Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
[TBL] [Abstract][Full Text] [Related]
7. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
Jones R; Prommer E; Backstedt D
Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
White WB; Kowey P; Diva U; Sostek M; Tummala R
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
[TBL] [Abstract][Full Text] [Related]
10. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
Corsetti M; Tack J
Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
[TBL] [Abstract][Full Text] [Related]
11. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
[TBL] [Abstract][Full Text] [Related]
12. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain.
Viscusi ER
Clin J Pain; 2019 Feb; 35(2):174-188. PubMed ID: 30289777
[TBL] [Abstract][Full Text] [Related]
13. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
van Malderen K; Halawi H; Camilleri M
Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
[TBL] [Abstract][Full Text] [Related]
16. Naloxegol , a new drug for the treatment of opioid-induced constipation.
Corsetti M; Tack J
Expert Opin Pharmacother; 2015 Feb; 16(3):399-406. PubMed ID: 25496063
[TBL] [Abstract][Full Text] [Related]
17. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.
Chokhavatia S; John ES; Bridgeman MB; Dixit D
Drugs Aging; 2016 Aug; 33(8):557-74. PubMed ID: 27417446
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
Ford AC; Brenner DM; Schoenfeld PS
Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
[TBL] [Abstract][Full Text] [Related]
19. Naloxegol for managing opioid-induced constipation.
Shelton KN; Clements JN
JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
[TBL] [Abstract][Full Text] [Related]
20. Improving the recognition and diagnosis of opioid-induced constipation in clinical practice.
Gupta A
J Fam Pract; 2015 Oct; 64(10 Suppl 1):. PubMed ID: 26561554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
